Good_老虎社区_美港股上老虎

股市搜搜搜
2021-12-13

Good

Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>

Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today ann

Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":604500228,"tweetId":"604500228","gmtCreate":1639407902856,"gmtModify":1639408039242,"author":{"id":3581591918943142,"idStr":"3581591918943142","authorId":3581591918943142,"authorIdStr":"3581591918943142","name":"股市搜搜搜","avatar":"https://static.tigerbbs.com/ecb301544fcb1c72efc07593fdb9ebcf","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":20,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good</p></body></html>","htmlText":"<html><head></head><body><p>Good</p></body></html>","text":"Good","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/604500228","repostId":1101330061,"repostType":4,"repost":{"id":"1101330061","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639402663,"share":"https://www.laohu8.com/m/news/1101330061?lang=zh_CN&edition=full","pubTime":"2021-12-13 21:37","market":"us","language":"en","title":"Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101330061","media":"Tiger Newspress","summary":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today ann","content":"<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 21:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.<img src=\"https://static.tigerbbs.com/fa70bd1f3f0b778ea773bf713c99c679\" tg-width=\"774\" tg-height=\"570\" referrerpolicy=\"no-referrer\">The&nbsp;company&nbsp;today&nbsp;announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM&nbsp;for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).</p><p><blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%。该公司今天宣布，美国。美国食品药品监督管理局（FDA）已批准ENTADFITM用于治疗由前列腺肥大引起的尿路症状，称为良性前列腺增生（BPH）。</blockquote></p><p> ENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.</p><p><blockquote>口服ENTADFI（非那雄胺和他达拉非）胶囊也被证明比非那雄胺单药治疗更有效地治疗由BPH引起的尿路症状，不良性副作用的可能性更小。ENTADFI剂量为每日一次口服一粒胶囊，FDA批准的适应症是在前列腺肥大的男性中开始治疗良性前列腺增生的体征和症状，最长可达26周。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VERU":"Veru Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101330061","content_text":"Veru jumped over 13% in premarket trading it announced FDA approval of ENTADFI.The company today announced that the U.S. Food and Drug Administration (FDA) has approved ENTADFITM for the treatment of urinary tract symptoms caused by an enlarged prostate called benign prostatic hyperplasia (BPH).\nENTADFI (finasteride and tadalafil) capsule for oral use has also been shown to be more effective to treat urinary tract symptoms caused by BPH with less potential for adverse sexual side effects compared to finasteride monotherapy. ENTADFI dosing is one capsule orally once a day, and the FDA-approved indication is to initiate treatment of the signs and symptoms of benign prostatic hyperplasia in men with an enlarged prostate for up to 26 weeks.","news_type":1,"symbols_score_info":{"VERU":0.9}},"isVote":1,"tweetType":1,"viewCount":2273,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Veru jumped over 13% in premarket trading as it announced FDA approval of ENTADFI<blockquote>Veru宣布FDA批准ENTADFI，盘前交易中股价上涨超过13%</blockquote>

评论（1）

热议股票